Gary Cutter PhD

Dr. Cutter is a Professor of Biostatistics and Head of the Section on Research Methods and Clinical Trials (RMCT Section). Dr. Cutter has a major interest in design, analysis, conduct and interpretation of clinical trials, epidemiologic studies and evaluation research.  He directs several national and multinational coordinating centers; a combination therapy trial of MS; a surgical trial in Myasthenia Gravis both funded by NINDS; an international registry of 33,000 MS patients supported by the Consortium of MS Centers. He directs the Coordinating Center for the Inhaled Nitric Oxide in premature infants and the Sildinafil in infants lung pilot trial, multi-center trials funded by the NHLBI Lung Division.  He is a co-director of the Core A in the Recessive Polycystic Kidney Disease Core Center. Director, Biostatistics/Bioinformatics Resource (BBR) Core Center for Acute Kidney Injury Research, UAB-USCand is Director, Center For Aids Research, Biostatistics Core, UAB and the PI of the Coordinating Center for one of the studies conducted by the Collaborative Antiviral Study Group. He is a member of various Data and Safety Monitoring Committees and advisory Committees and is on the Executive Committee for UAB's CTSA, the CTTS.